Incidence of postoperative infection among radical cystectomy patients who underwent intestinal urinary diversion

A total of 50 patients who underwent radical cystectomy with intestinal urinary diversion between October 2008 and April 2017 were included in this study. Sulbactam/ampicillin, cefazolin or cefmetazole were intravenously administered before the operation and this administration was continued twice a day until postoperative day 2. Surgical site infection (SSI), remote infection (RI) and febrile urinary tract infection (f-UTI) were surveyed until postoperative day 30. From July 2009, forty-three patients received antibiotics prior to stent removal. Overall the incidence of POI was 40% (20/50). SSI, RI and f-UTI were observed in 7, 1 and 12 patients, respectively. Among the f-UTI patients, 8 patients developed a f-UTI following the removal of a ureteral stent. Although 5 out of the 7 patients who did not receive the prophylaxis suffered from a f-UTI, only 3 out of the 43 patients who did receive the prophylaxis went on to develop a f-UTI. The incidence of POI, including f-UTI, was relatively high. However, antimicrobial prophylaxis reduced the incidence of f-UTI after the removal of a ureteral stent.